BRCA1 and ovarian cancer: The impact of BRCA1/2 mutations on steroid hormone activity was assessed by examining endometrial thickness for each menstrual cycle day as an index of hormone regulation in a cohort of 228 women in the UK Familial Ovarian Cancer Screening Study (78).